Skip to content

Development of a Molecular Diagnosing Platform for Relieving Periodontal Symptoms

Development of a Molecular Diagnosing Platform for Relieving Periodontal Symptoms

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03345329
Enrollment
100
Registered
2017-11-17
Start date
2015-10-01
Completion date
2016-09-30
Last updated
2017-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peri-Implantitis, Periodontal Diseases

Brief summary

More than ninety percent of adults in Taiwan are suspected to carry periodontal disease, which causes bad breath, swollen and bleeding gums, plaque and even tooth loss. Half of the patients, however, are ignorance these clinical syndromes because of no obvious pain. In this study, the investigators selected six periodontal disease-associated bacteria strains, including Porphyromonas gingivalis (Pg), Fusobacterium nucleatum (Fn), Actinobacillus actinomycetemcomitans (Aa), Tannerella forsythia (Tf), Treponema denticola (Td) and Prevotella intermedia (Pi) as diagnostic markers. Using real-time PCR and MALDI Biotyper, the investigators will establish the database of oral microorganisms in Taiwanese people, providing periodontal disease clinical markers of high-risk groups and the basis for personal medicine of therapy in the future.

Interventions

None listed

Sponsors

General Biologicals Corporation
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
25 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Age≧25 2. 3≦periodontal screening and recording≦4 3. 16 natural teeths and 6 front teeth at lesat 4. GI≧1.25 5. PI≧2

Exclusion criteria

1. People who have oral lesion, dental braces, denture, mouthwash allergy, or serious systemic disease 2. People who have ever eaten antibiotics and Anti-inflammatory drugs over the last 6 months 3. People who have ever eaten Immunosuppressive drugs, antiepileptic drugs, antihypertensive drugs, or anticoagulant 4. Pregnant women or the woman who eat birth control pills

Design outcomes

Primary

MeasureTime frameDescription
The change of PSR score, GI, PI, and oral bacteria strains between periodontal disease patients and healthy people after receiving periodontal therapy and using mouthwash9 monthTo compare the value of PSR score (0-4 point), GI (0-4 point), and PI (0-5 point) with periodontal disease patients older than 60 years of age, periodontal disease patients younger than 60 years of age and healthy people after receiving periodontal therapy and using mouthwash. Oral bacteria strains are also compared with these groups.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026